MichaelHowardBlochMD

Psychiatry • Hamden, CT

Child & Adolescent Psychiatry

Assistant Professor, Child Study Center, Yale University School of Medicine

Join to view full profile

Dr. Bloch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bloch's full profile

Already have an account?

Office
3 Woodbine St
Hamden, CT 06517
Phone+1 203-785-7683

Fax+1 203-785-7611

Education & Training

Yale-New Haven Medical CenterFellowship, Child and Adolescent Psychiatry, 2008 - 2010
Yale-New Haven Medical CenterResidency, Psychiatry, 2004 - 2010
Yale School of MedicineClass of 2004

Certifications & Licensure

CT State Medical License 2007 - 2025
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

N-Acetylcysteine for Pediatric Trichotillomania Start of enrollment: 2009 Oct 01
Completed
Phase 2
N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder Start of enrollment: 2012 Jul 01
Completed
Phase 2
N-acetylcysteine (NAC) for Children With Tourette Syndrome Start of enrollment: 2010 Jul 01
Completed
Phase 2
Ketamine Infusion for Obsessive-Compulsive Disorder Start of enrollment: 2009 Feb 01
Completed
Phase 2
Ketamine Infusion for Social Anxiety Disorder Start of enrollment: 2015 Jan 02
Completed
Early Phase 1
FAAH Inhibitor Trial for Adults With Tourette Syndrome Start of enrollment: 2014 May 01
Terminated
Phase 1
Ketamine Infusion for Adolescent Depression and Anxiety Start of enrollment: 2015 Oct 01
Completed
Phase 4
Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder Start of enrollment: 2017 Jan 01
Completed
Phase 2, Phase 3
A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome Start of enrollment: 2022 May 01
Not yet recruiting
Not Applicable
Roles: Principal Investigator, Contact
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults Start of enrollment: 2023 Oct 01
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine Start of enrollment: 2022 Jan 21
Recruiting
Phase 2
Roles: Principal Investigator
Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome Start of enrollment: 2022 Mar 01
Not yet recruiting
Not Applicable
Roles: Principal Investigator, Contact
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults Start of enrollment: 2023 Jan 31
Recruiting
Phase 3
Roles: Contact
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder Start of enrollment: 2023 Aug 16
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

4 citations
Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression.
Alice Lineham, Victor J Avila-Quintero, Michael H Bloch, Jennifer Dwyer
Journal of Child and Adolescent Psychopharmacology. 2024-03-01
1 citations
Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.
Luis C Farhat, José M Flores, Victor J Avila-Quintero, Guilherme V Polanczyk, Andrea Cipriani
JAMA Psychiatry. 2024-02-01
2 citations
Revisiting best practices: a reflection on the online evaluation and treatment of ADHD and implications for future practice.
Max J Rolison, Michael H Bloch
Child and Adolescent Psychiatry and Mental Health. 2023-03-28

Journal Articles

Systematic Review and Meta‐Analysis: Dose–Response Curve of SSRIs and SNRIs in Anxiety Disorders
Michael Bloch, MD, Depression and Anxiety

Grant Support

Longitudinal Structural MRI Study Of Adulthood Outcome In Tourette SyndromeNational Institute Of Mental Health2010–2012